Chronic Kidney
Disease Management
Staging by eGFR and albuminuria, slowing progression, and treating complications of declining renal function.
What Is CKD?
Chronic kidney disease is defined as abnormalities of kidney structure or function present for at least 3 months, with implications for health. The key markers are a reduced filtration rate and persistent kidney damage.
Two Key Measurements
Estimating eGFR
eGFR is estimated from serum creatinine using equations like CKD-EPI. Conceptually, filtration is inversely related to creatinine:
GFR Staging (G1–G5)
The KDIGO Risk Grid
Risk of CKD progression is determined by combining G stage (eGFR) with A stage (albuminuria). Higher numbers on either axis push the patient into a higher-risk zone.
Albuminuria Categories
AKI vs. CKD
| Acute Kidney Injury | Chronic Kidney Disease | |
|---|---|---|
| Timeframe | Hours to days | \( \geq 3 \) months |
| Kidney size | Usually normal | Often small / echogenic |
| Anemia | Typically absent | Common (low EPO) |
| Reversibility | Often reversible | Usually progressive |
A Stepwise Approach
Slowing Progression
Example 1: Staging
Example 2: Hyperkalemia
Example 3: Anemia of CKD
Common Mistakes
Complications Summary
| Problem | Mechanism | Management |
|---|---|---|
| Anemia | Low EPO | Iron, then ESA |
| Bone disease | Low vit D, high \( \text{PO}_4 \), high PTH | Phosphate binders, vit D |
| Acidosis | Low acid excretion | Sodium bicarbonate |
| Hyperkalemia | Reduced K⁺ excretion | Diet, binders, diuretics |
| Volume overload | Sodium retention | Loop diuretics, salt restriction |
Question 1 of 5
A patient has a stable eGFR of 70 but a UACR of 350 mg/g confirmed over 4 months. How should this be classified?
Question 2 of 5
A diabetic with CKD and albuminuria is started on an ACEi. Two weeks later creatinine rises 22% and \( \text{K}^+ \) is 5.0. What is the best next step?
Question 3 of 5
A type 2 diabetic with CKD G3aA2 is already on a maximally tolerated ACEi. Which agent best slows further progression and adds cardiorenal benefit?
Question 4 of 5
A CKD G4 patient has \( \text{Hgb} = 9.0\,\text{g/dL} \), normal MCV, and fatigue. What should be done before starting an erythropoiesis-stimulating agent?
Question 5 of 5
A CKD G4 patient on an ACEi presents with \( \text{K}^+ = 6.2 \) and peaked T waves. What is the first intervention?